TY - JOUR
T1 - Safety evaluation of the food enzyme α-amylase from the genetically modified Bacillus licheniformis strain DP-Dzb52
AU - EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP)
AU - Lambré, Claude
AU - Barat Baviera, José Manuel
AU - Bolognesi, Claudia
AU - Cocconcelli, Pier Sandro
AU - Crebelli, Riccardo
AU - Gott, David Michael
AU - Grob, Konrad
AU - Lampi, Evgenia
AU - Mengelers, Marcel
AU - Mortensen, Alicja
AU - Rivière, Gilles
AU - Steffensen, Inger Lise
AU - Tlustos, Christina
AU - van Loveren, Henk
AU - Vernis, Laurence
AU - Zorn, Holger
AU - Kärenlampi, Sirpa
AU - Penninks, André
AU - Andryszkiewicz, Magdalena
AU - Gomes, Ana
AU - Kovalkovičová, Natália
AU - Liu, Yi
AU - Maia, Joaquim
AU - Engel, Karl Heinz
AU - Chesson, Andrew
N1 - Publisher Copyright:
© 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
PY - 2021/4
Y1 - 2021/4
N2 - The food enzyme α-amylase (1,4-α-d-glucan glucanohydrolase; EC 3.2.1.1) is produced with the genetically modified Bacillus licheniformis strain DP-Dzb52 by Danisco US Inc. The production strain contains multiple copies of an antimicrobial resistance gene. However, based on the absence of viable cells and DNA from the production organism in the food enzyme, this is not considered to be a risk. The α-amylase is intended to be used in starch processing for the production of glucose syrups, brewing processes and distilled alcohol production. Since residual amounts of the food enzyme are removed by the purification steps applied during the production of glucose syrups and distillation, no dietary exposure was calculated. Based on the maximum use levels recommended for the brewing processes and individual data from the EFSA Comprehensive European Food Consumption Database, dietary exposure to the enzyme–total organic solids (TOS) was estimated to be up to 0.145 TOS/kg body weight per day in European populations. The toxicity studies were carried out with another α-amylase from B. licheniformis strain DP-Dzb54, considered by the Panel as a suitable substitute. Toxicological tests indicated that there was no concern with respect to genotoxicity or systemic toxicity. A no observed adverse effect level was identified in rats which, compared with the dietary exposure, results in a margin of exposure of at least 750. A search for similarity of the amino acid sequence to known allergens was made and one match was found. The Panel considered that, under the intended conditions of use, the risk of allergic sensitisation and elicitation reactions can be excluded in distilled alcohol production and is considered low when the enzyme is used in starch processing and brewing. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.
AB - The food enzyme α-amylase (1,4-α-d-glucan glucanohydrolase; EC 3.2.1.1) is produced with the genetically modified Bacillus licheniformis strain DP-Dzb52 by Danisco US Inc. The production strain contains multiple copies of an antimicrobial resistance gene. However, based on the absence of viable cells and DNA from the production organism in the food enzyme, this is not considered to be a risk. The α-amylase is intended to be used in starch processing for the production of glucose syrups, brewing processes and distilled alcohol production. Since residual amounts of the food enzyme are removed by the purification steps applied during the production of glucose syrups and distillation, no dietary exposure was calculated. Based on the maximum use levels recommended for the brewing processes and individual data from the EFSA Comprehensive European Food Consumption Database, dietary exposure to the enzyme–total organic solids (TOS) was estimated to be up to 0.145 TOS/kg body weight per day in European populations. The toxicity studies were carried out with another α-amylase from B. licheniformis strain DP-Dzb54, considered by the Panel as a suitable substitute. Toxicological tests indicated that there was no concern with respect to genotoxicity or systemic toxicity. A no observed adverse effect level was identified in rats which, compared with the dietary exposure, results in a margin of exposure of at least 750. A search for similarity of the amino acid sequence to known allergens was made and one match was found. The Panel considered that, under the intended conditions of use, the risk of allergic sensitisation and elicitation reactions can be excluded in distilled alcohol production and is considered low when the enzyme is used in starch processing and brewing. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.
KW - 1,4-α-d-glucan glucanohydrolase
KW - Bacillus licheniformis
KW - EC 3.2.1.1
KW - food enzyme
KW - genetically modified microorganism
KW - glycogenase
KW - α-amylase
UR - http://www.scopus.com/inward/record.url?scp=85105049225&partnerID=8YFLogxK
U2 - 10.2903/j.efsa.2021.6564
DO - 10.2903/j.efsa.2021.6564
M3 - Article
AN - SCOPUS:85105049225
SN - 1831-4732
VL - 19
JO - EFSA Journal
JF - EFSA Journal
IS - 4
M1 - e06564
ER -